Mannalithara A - Search Results

1

Optimal population screening strategies for liver fibrosis associated with metabolic dysfunction-associated steatotic liver disease.

Kim WR, Mannalithara A, Charu V, Chung N, Kwong A, Kwo PY, Torok NJ, Asch SM, Kim SH. Kim WR, et al. Among authors: mannalithara a. Am J Gastroenterol. 2025 Jan 3. doi: 10.14309/ajg.0000000000003268. Online ahead of print. Am J Gastroenterol. 2025. PMID: 39749918

2

Migration of Patients for Liver Transplantation and Waitlist Outcomes.

Kwong AJ, Mannalithara A, Heimbach J, Prentice MA, Kim WR. Kwong AJ, et al. Among authors: mannalithara a. Clin Gastroenterol Hepatol. 2019 Oct;17(11):2347-2355.e5. doi: 10.1016/j.cgh.2019.04.060. Epub 2019 May 8. Clin Gastroenterol Hepatol. 2019. PMID: 31077826

3

Potential Benefits of Switching Liver Transplant Recipients to Tenofovir Alafenamide Prophylaxis.

Sripongpun P, Mannalithara A, Kwo PY, Kim WR. Sripongpun P, et al. Among authors: mannalithara a. Clin Gastroenterol Hepatol. 2020 Mar;18(3):747-749. doi: 10.1016/j.cgh.2019.05.057. Epub 2019 Jun 11. Clin Gastroenterol Hepatol. 2020. PMID: 31271737

4

Reply to: "The decreasing predictive power of MELD in an era of changing etiology of liver disease".

Kwong A, Mannalithara A, Kim WR. Kwong A, et al. Among authors: mannalithara a. Am J Transplant. 2020 Mar;20(3):901-902. doi: 10.1111/ajt.15733. Epub 2019 Dec 27. Am J Transplant. 2020. PMID: 31814299 Free article. No abstract available.

5

Tenofovir Alafenamide Attenuates Effects of Diabetes and Body Mass on Serum Alanine Aminotransferase Activities in Patients With Chronic Hepatitis B.

Sripongpun P, Kim WR, Mannalithara A, Kwong A, Daugherty T, Goel A, Kwo PY. Sripongpun P, et al. Among authors: mannalithara a. Clin Gastroenterol Hepatol. 2022 Jan;20(1):230-232. doi: 10.1016/j.cgh.2020.11.047. Epub 2020 Dec 4. Clin Gastroenterol Hepatol. 2022. PMID: 33285291

6

The steatosis-associated fibrosis estimator (SAFE) score: A tool to detect low-risk NAFLD in primary care.

Sripongpun P, Kim WR, Mannalithara A, Charu V, Vidovszky A, Asch S, Desai M, Kim SH, Kwong AJ. Sripongpun P, et al. Among authors: mannalithara a. Hepatology. 2023 Jan 1;77(1):256-267. doi: 10.1002/hep.32545. Epub 2022 May 24. Hepatology. 2023. PMID: 35477908 Free PMC article.

7

Mortality in patients with end-stage liver disease above model for end-stage liver disease 3.0 of 40.

Kim WR, Mannalithara A, Kwo PY, Bonham CA, Kwong A. Kim WR, et al. Among authors: mannalithara a. Hepatology. 2023 Mar 1;77(3):851-861. doi: 10.1002/hep.32770. Epub 2023 Feb 17. Hepatology. 2023. PMID: 36052665 Free PMC article.

8

MELD 3.0 for adolescent liver transplant candidates.

Kwong AJ, Zhang KY, Ebel N, Mannalithara A, Kim WR. Kwong AJ, et al. Among authors: mannalithara a. Hepatology. 2023 Aug 1;78(2):540-546. doi: 10.1097/HEP.0000000000000352. Epub 2023 Mar 22. Hepatology. 2023. PMID: 36943091 Free PMC article.

9

Hepatitis C Screening in Post-Baby Boomer Generation Americans: One Size Does Not Fit All.

Sripongpun P, Udompap P, Mannalithara A, Downing NL, Vidovszky AA, Kwong AJ, Goel A, Kwo PY, Kim WR. Sripongpun P, et al. Among authors: mannalithara a. Mayo Clin Proc. 2023 Sep;98(9):1335-1344. doi: 10.1016/j.mayocp.2023.02.009. Mayo Clin Proc. 2023. PMID: 37661141

10

Benchmarking clinical risk prediction algorithms with ensemble machine learning for the noninvasive diagnosis of liver fibrosis in NAFLD.

Charu V, Liang JW, Mannalithara A, Kwong A, Tian L, Kim WR. Charu V, et al. Among authors: mannalithara a. Hepatology. 2024 Nov 1;80(5):1184-1195. doi: 10.1097/HEP.0000000000000908. Epub 2024 Apr 30. Hepatology. 2024. PMID: 38687634

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

61 results

Search Page

Filters